A Contract Research Organisation
ADME BIOANALYSES is a Contract Research Organisation that was founded in 1987 by Dr. Patrick DUCHENE.
After a relevant experience in Pharmaceutical industry R&D, Patrick DUCHENE, Ph.D., first established the company in Sophia Antipolis (near Nice) then moved it to new facilities in Vergèze, between Montpellier and Nîmes, in 1999.
- ADME BIOANALYSES provides high quality services to :
- the pharmaceutical industry in the fields of pharmacokinetics and metabolism and,
- the agropharmaceutical industry in the fields of residue, metabolism and worker exposure assessment.
Through regular investments and continuous staff training, ADME BIOANALYSES ensures optimisation of registration timelines.
In 2005, ADME BIOANALYSES joined the Eurofins Scientific Group to expand its technological and geographical scope.
This new organisation has allowed the company to strengthen its position in the marked and to speed up development for an even higher quality technical service.
EUROFINS Worlwide excellence in laboratory analysis
Eurofins analyses everything that impacts human health and safety.
Eurofins Scientific is a leading international group of laboratories providing an unparalleled range of testing and support services to the pharmaceutical, food, environmental and consumer products industries and to governments.
Comprehensive services and unmatched expertise
With over 70 state-of-the-art laboratories in 20 countries, Eurofins is a worldwide leader in its field.
The Group offers a portfolio of over 10,000 reliable analytical methods for characterising the safety, identity, purity, composition, authenticity and origin of products and biological substances. Through research and development, in-licensing and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical sciences to offer its customers unique testing solutions.
A commitment to top quality and customer service
The Eurofins Group is committed to provide the highest quality services, accurate results in time and, if requested, expert advice by highly qualified staff. The reliability and accuracy of its data help customers make the right decisions on risks and meet their increasingly stringent quality and safety standards and the demands of regulatory authorities around the world.
Permanent innovation and support by the market leader
Few testing laboratories can combine the level of expertise, technological leadership, attention to quality and customer service that have made Eurofins the global leader in many of the fields where it is active. Considerable investment in innovation, technology, IT and logistics and very large sample volumes ensure that customers enjoy high standards of quality at reasonable prices.
Eurofins – Facts & Figures
- Over 150 laboratories and 5,000 employees
- Over 25,000 reliable methods
- Presence in 29 countries
- Revenues of ca. about € 492 millions in 2007
- Consistently profitable operations
- 100,000 m² of state-of-the-art laboratories equipped with the latest analytical technology (e.g. 300 GC, 150 GC-MS, 15 high-resolution GC-MS, 400 HPLC, 40 LC-MS/MS, 70 ICP, 25 real-time PCR systems, 20 high-throughput DNA sequencers, etc.)
